CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		18 Months Ended
	Aug. 11, 2023	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023
Cash flows from Operating Activities
Net increase in net assets resulting from operations		$ 4,510,399	$ 617,112	$ 7,086,067	$ 585,915
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments				(41,418,778)	(79,461,775)
Proceeds from sales and repayments of investments				12,580,637	690,802
Net change in unrealized (appreciation) depreciation on investments		(1,819,403)	82,562	(1,747,377)	190,610
Net change in unrealized appreciation foreign currency translations		27	(579)	(6,193)	(579)
Amortization of premium and accretion of discount, net				(221,155)	(49,672)
Amortization of loan structure fees				298,970	144,559
Amortization of deferred offering costs		41,106	62,954	98,729	97,831
Changes in other assets and liabilities
Increase in interest receivable				(279,075)	(488,877)
Increase in other receivable					(12,997)
Increase in related party receivable				(94,964)	(383,465)
Decrease (increase) in expense reimbursements receivable from the Advisor				26,409	(245,356)
Decrease in prepaid expenses				70,588	45,204
Decrease in due to affiliate					(460,085)
Decrease in trustees' fees payable					(42,000)
Increase in administrative services payable				26,149	64,174
(Decrease) increase in interest payable				(389,912)	92,113
Increase in income incentive fees payable				30,837	77,677
Increase in capital gains incentive fees payable				124,892
Increase in unearned revenue				68,341	365,612
Increase in income tax payable				8,390
Increase (decrease) in other accrued expenses and liabilities				7,771	(57,107)
Net Cash Used in Operating Activities				(23,729,674)	(78,847,416)
Cash flows from Financing Activities
Proceeds from issuance of common shares of beneficial interest	$ 1,095,959			10,275,069	55,000,000	$ 91,668,962
Offering costs paid for common shares of beneficial interest issued				(131,095)	(121,807)
Stockholder distributions paid				(4,115,942)
Borrowings under Credit Facilities				72,000,000	59,950,000
Repayments of Credit Facilities				(57,415,000)	(13,500,000)
Financing costs paid on Credit Facilities				(352,744)	(429,573)
Short-term loan repayments				(11,250,000)	25,000,000
Net Cash Provided by Financing Activities				9,010,288	125,898,620
Net (Decrease) Increase in Cash and Cash Equivalents				(14,719,386)	47,051,204
Cash and Cash Equivalents Balance at Beginning of period	$ 750,437			15,469,823
Cash and Cash Equivalents Balance at End of Period		$ 750,437	$ 47,051,204	750,437	47,051,204	$ 750,437
Supplemental and Non-Cash Activities
Cash paid for interest expense				3,616,852	113,999
Increase in deferred offering costs				32,366	$ 23,976
Income and excise tax paid				8,300
Value of common shares of beneficial interest issued pursuant to Dividend Reinvestment Plan				155,615
Increase in dividends payable				$ 910,953